Advances in upper airway diseases and allergen immunotherapy in 2007

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 3, 2008, Pages 481-487

  Saltoun, Carol ^a   Avila, Pedro C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

allergen immunotherapy; conjunctivitis; nasal polyps; Rhinitis; sinusitis

Indexed keywords

BETA 1,3 GLUCAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; GELATINASE B; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; IMMUNOMODULATING AGENT; NEUTROPHIL COLLAGENASE; OLOPATADINE; OMALIZUMAB; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR 9;

ALLERGENICITY; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CELL STIMULATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IMMUNOGENICITY; IMMUNOTHERAPY; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; RISK FACTOR; SENSITIZATION; SINUSITIS; SYMPTOMATOLOGY; T LYMPHOCYTE; VERNAL CONJUNCTIVITIS;

ADMINISTRATION, SUBLINGUAL; ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; CONJUNCTIVITIS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; RESPIRATORY TRACT DISEASES; RHINITIS, ALLERGIC, SEASONAL; SINUSITIS;

EID: 50649123196     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.06.027     Document Type: Article

References (63)

1. Rondon C., Romero J.J., Lopez S., Antunez C., Martin-Casanez E., Torres M.J., et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 119 (2007) 899-905
2. Valero A., Ferrer M., Sastre J., Navarro A.M., Monclus L., Marti-Guadano E., et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and Its Impact on Asthma severity items. J Allergy Clin Immunol 120 (2007) 359-365
3. Janson C., Asbjornsdottir H., Birgisdottir A., Sigurjonsdottir R.B., Gunnbjornsdottir M., Gislason D., et al. The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia, and Sweden. J Allergy Clin Immunol 120 (2007) 673-679
4. Walker S., Khan-Wasti S., Fletcher M., Cullinan P., Harris J., and Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 120 (2007) 381-387
5. Burgess J.A., Walters E.H., Byrnes G.B., Matheson M.C., Jenkins M.A., Wharton C.L., et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 120 (2007) 863-869
6. Matheson M.C., Erbas B., Balasuriya A., Jenkins M.A., Wharton C.L., Tang M.L., et al. Breast-feeding and atopic disease: a cohort study from childhood to middle age. J Allergy Clin Immunol 120 (2007) 1051-1057
7. Yamada J., Hamuro J., Hatanaka H., Hamabata K., and Kinoshita S. Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study. J Allergy Clin Immunol 119 (2007) 1119-1126
8. Kaiser H.B., Naclerio R.M., Given J., Toler T.N., Ellsworth A., and Philpot E.E. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 119 (2007) 1430-1437
9. Patel P., Roland P.S., Marple B.F., Benninger P.J., Margalias H., Brubaker M., et al. An assessment of the onset and duration of action of olopatadine nasal spray. Otolaryngol Head Neck Surg 137 (2007) 918-924
10. Moore W.C., Bleecker E.R., Curran-Everett D., Erzurum S.C., Ameredes B.T., Bacharier L., et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119 (2007) 405-413
11. Cannady S.B., Batra P.S., Leahy R., Citardi M.J., Janocha A., Ricci K., et al. Signal transduction and oxidative processes in sinonasal polyposis. J Allergy Clin Immunol 120 (2007) 1346-1353
12. Kim T.H., Lee S.H., Lee H.M., Jung H.H., Lee S.H., Cho W.S., et al. Increased expression of glycoprotein 340 in the ethmoid sinus mucosa of patients with chronic sinusitis. Arch Otolaryngol Head Neck Surg 133 (2007) 1111-1114
13. Psaltis A.J., Bruhn M.A., Ooi E.H., Tan L.W., and Wormald P.J. Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis. Laryngoscope 117 (2007) 2030-2035
14. Hall-Stoodley L., Hu F.Z., Gieseke A., Nistico L., Nguyen D., Hayes J., et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296 (2006) 202-211
15. Post J.C., Hiller N.L., Nistico L., Stoodley P., and Ehrlich G.D. The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg 15 (2007) 347-351
16. Kostamo K., Tervahartiala T., Sorsa T., Richardson M., and Toskala E. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope 117 (2007) 638-643
17. Ramanathan Jr. M., Lee W.K., Dubin M.G., Lin S., Spannhake E.W., and Lane A.P. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 21 (2007) 110-116
18. Ramanathan Jr. M., Spannhake E.W., and Lane A.P. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor. Laryngoscope 117 (2007) 1839-1843
19. Fokkens W., Lund V., and Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 20 (2007) 1-136
20. Rosenfeld R.M. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg 137 (2007) 365-377
21. Nakatani S., Ebihara N., and Murakami A. Stem cell factor in the tear fluid of vernal keratoconjunctivitis patients. Jpn J Ophthalmol 51 (2007) 474-476
22. Inada N., Shoji J., Hoshino M., and Sawa M. Evaluation of total and allergen-specific secretory IgA in tears of allergic conjunctival disease patients. Jpn J Ophthalmol 51 (2007) 338-342
23. Shoji J., Kawaguchi A., Gotoh A., Inada N., and Sawa M. Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients. Jpn J Ophthalmol 51 (2007) 332-337
24. Lambiase A., Normando E.M., Vitiello L., Micera A., Sacchetti M., Perrella E., et al. Natural killer cells in vernal keratoconjunctivitis. Mol Vis 13 (2007) 1562-1567
25. Bozkurt B., Akyurek N., Irkec M., Erdener U., and Memis L. Immunohistochemical findings in prosthesis-associated giant papillary conjunctivitis. Clin Exp Ophthalmol 35 (2007) 535-540
26. Abelson M.B., Spangler D.L., Epstein A.B., Mah F.S., and Crampton H.J. Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge. Curr Eye Res 32 (2007) 1017-1022
27. Swamy B.N., Chilov M., McClellan K., and Petsoglou C. Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data. Ophthalmic Epidemiol 14 (2007) 311-319
28. Hens G., Bobic S., Reekmans K., Ceuppens J.L., and Hellings P.W. Rapid systemic uptake of allergens through the respiratory mucosa. J Allergy Clin Immunol 120 (2007) 472-474
29. Bousquet J., Van Cauwenberge P., and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 suppl (2001) S147-S334
30. Gern J.E., Brooks G.D., Meyer P., Chang A., Shen K., Evans M.D., et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol 117 (2006) 72-78
31. Sayers I., Severn W., Scanga C.B., Hudson J., Le Gros G., and Harper J.L. Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol 114 (2004) 302-309
32. Hansen G., Yeung V.P., Berry G., Umetsu D.T., and DeKruyff R.H. Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18. J Immunol 164 (2000) 223-230
33. DeWester J., Philpot E.E., Westlund R.E., Cook C.K., and Rickard K.A. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 24 (2003) 331-337
34. Bielory L. Intranasal corticosteroids reduce ocular symptoms of allergic rhinitis as a class effect. J Allergy Clin Immunol 121 (2008) 538-539
35. van Oene C.M., van Reij E.J., Sprangers M.A., and Fokkens W.J. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy 62 (2007) 1359-1371
36. Juniper E.F., and Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21 (1991) 77-83
37. Juniper E.F., Thompson A.K., Ferrie P.J., and Roberts J.N. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 104 (1999) 364-369
38. Piccirillo J.F., Edwards D., Haiduk A., Yonan C., and Thawley S.E. Psychometric and clinimetric validity of the 31-item rhinosinusitis outcome measure (RSOM-31). Am J Rhinol 9 (1995) 297-306
39. Atlas S.J., Metson R.B., Singer D.E., Wu Y.A., and Gliklich R.E. Validity of a new health-related quality of life instrument for patients with chronic sinusitis. Laryngoscope 115 (2005) 846-854
40. Ding G.Q., Zheng C.Q., and Bagga S.S. Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis. Arch Otolaryngol Head Neck Surg 133 (2007) 1097-1103
41. Pynnonen M.A., Mukerji S.S., Kim H.M., Adams M.E., and Terrell J.E. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg 133 (2007) 1115-1120
42. Bonini S., Gramiccioni C., Bonini M., and Bresciani M. Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review. Curr Opin Allergy Clin Immunol 7 (2007) 446-449
43. Pflugfelder S.C., and Stern M.E. Future directions in therapeutic interventions for conjunctival inflammatory disorders. Curr Opin Allergy Clin Immunol 7 (2007) 450-453
44. Leonardi A., Brun P., Di Stefano A., Motterle L., and Abatangelo G. Matrix metalloproteases in vernal keratoconjunctivitis, nasal polyps and allergic asthma. Clin Exp Allergy 37 (2007) 872-879
45. Nelson H.S. Allergen immunotherapy: where is it now?. J Allergy Clin Immunol 119 (2007) 769-779
46. Akdis M., and Akdis C.A. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119 (2007) 780-791
47. Pajno G.B. Sublingual immunotherapy: the optimism and the issues. J Allergy Clin Immunol 119 (2007) 796-801
48. Larche M. Update on the current status of peptide immunotherapy. J Allergy Clin Immunol 119 (2007) 906-909
49. Valenta R., and Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol 119 (2007) 826-830
50. Passalacqua G., and Durham S.R. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 119 (2007) 881-891
51. Joint Task Force on Practice Parameters. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 120 suppl (2007) S25-S85
52. Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 90 (2003) 1-40
53. Coifman R.E., and Cox L.S. 2006 American Academy of Allergy, Asthma & Immunology member immunotherapy practice patterns and concerns. J Allergy Clin Immunol 119 (2007) 1012-1013
54. Didier A., Malling H.J., Worm M., Horak F., Jager S., Montagut A., et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 120 (2007) 1338-1345
55. Roder E., Berger M.Y., Hop W.C., Bernsen R.M., de Groot H., and Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 119 (2007) 892-898
56. Kinaciyan T., Jahn-Schmid B., Radakovics A., Zwolfer B., Schreiber C., Francis J.N., et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 119 (2007) 937-943
57. Bolhaar S.T., Tiemessen M.M., Zuidmeer L., van Leeuwen A., Hoffmann-Sommergruber K., Bruijnzeel-Koomen C.A., et al. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 34 (2004) 761-769
58. Bohle B., Kinaciyan T., Gerstmayr M., Radakovics A., Jahn-Schmid B., and Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 120 (2007) 707-713
59. Pajno G.B., Caminiti L., Vita D., Barberio G., Salzano G., Lombardo F., et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 120 (2007) 164-170
60. Klunker S., Saggar L.R., Seyfert-Margolis V., Asare A.L., Casale T.B., Durham S.R., et al. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol 120 (2007) 688-695
61. Metz-Favre C., Linhart B., Focke-Tejkl M., Purohit A., de Blay F., Valenta R., et al. Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule. J Allergy Clin Immunol 120 (2007) 315-321
62. Gonzalez-Rioja R., Ibarrola I., Arilla M.C., Ferrer A., Mir A., Andreu C., et al. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy. J Allergy Clin Immunol 120 (2007) 602-609
63. Wallner M., Stocklinger A., Thalhamer T., Bohle B., Vogel L., Briza P., et al. Allergy multivaccines created by DNA shuffling of tree pollen allergens. J Allergy Clin Immunol 120 (2007) 374-380